ChatGPTClaudePerplexity
Clinical Protocol 2026|
Evidence-Based

Enteropathy-type (intestinal) T-cell lymphoma

Enteropathy-type T-cell lymphoma is a rare and aggressive type of cancer that affects the immune system and the intestines.

Dr. Dinesh Kumar

Verified by Dr. Dinesh Kumar

Verified

15+ Yrs Exp | MD, Specialist Physician

8/10Severity Score
Critical Management

Treatment Decisions Engine

Clinically-validated pathway for Enteropathy-type (intestinal) T-cell lymphoma

Critical Decision Checkpoints

Decision Trigger

IF: Diagnosis of enteropathy-type T-cell lymphoma

Recommendation:Refer to a hematologist-oncologist

Decision Trigger

IF: Completion of chemotherapy

Recommendation:Follow-up imaging studies to assess response

Stage I

6-12 months
Est: ₹5k - 15k

Options & Approaches

  • Chemotherapy
  • Radiation therapy

When this is chosen

"Lymphoma confined to the intestines"

Educating patients on conservative options.

Stage II

Surgical Intervention
1-2 years
Est: ₹80k - 1.5L

Options & Approaches

  • Chemotherapy
  • Radiation therapy
  • Surgery

When this is chosen

"Lymphoma has spread to nearby lymph nodes"

Educating patients on surgical options.

Stage III

Surgical Intervention
1-2 years
Est: ₹80k - 1.5L

Options & Approaches

  • Chemotherapy
  • Radiation therapy
  • Surgery

When this is chosen

"Lymphoma has spread to distant lymph nodes or organs"

Educating patients on surgical options.

Neutral Information Layer

Unbiased • Evidence-Based • Clinical

Health Mudraa's Treatment Engine objective is clarity. We explain treatment paths so you can have better conversations with your doctor.

Diagnostic Strategy

Clinical Decision Support System (CDSS) for Enteropathy-type (intestinal) T-cell lymphoma

Initial Presentation

Common reports

Abdominal painDiarrheaWeight loss

Differential Filter

Is it truly Enteropathy-type (intestinal) T-cell lymphoma?

  • Vs. Celiac disease
  • Vs. Crohn's disease
  • Vs. Ulcerative colitis

Confirmed Diagnosis

Protocol Start

Based on clinical exams and indicated diagnostic tests.

Clinical Rationale: This pathway prioritizes the exclusion of life-threatening differentials before proceeding to definitive diagnostics.

NICE/WHO Standards

Care Plan

Stage 0: Conservative

First-Line Home Care

Non-invasive interventions focusing on symptoms and lifestyle.

Home Remedies

Gluten-free diet

6/10

May help manage symptoms in some cases

Alternative Care

Lifestyle

Stress management

Useful for overall well-being

Stage 1: Primary Allopathy

Standard Clinical Protocol

Verified medical treatments and pharmaceutical interventions.

  • Chemotherapy
  • Radiation therapy
Stage 2: Specialist Care

Advanced Interventions

Surgical or specialized procedures for persistent cases.

Criteria: Lymphoma has spread to nearby lymph nodes

  • ChemotherapySurgical
  • Radiation therapySurgical
  • SurgerySurgical

Emergency Triggers

  • Severe abdominal pain

  • Vomiting blood

  • Black tarry stools

Recovery Milestones

months6-12

Completion of chemotherapy

Clinical Benchmark

Health Mudraa Bundles

Treatment Packages

Transparently priced, end-to-end packages designed by top hospitals for faster recovery.

Best for Diagnosis
4.9

Enteropathy-type (intestinal) T-cell lymphoma Diagnostic Bundle

4,9997,500

All Inclusive Price

  • Full Blood Panel
  • Specialist Consultation
  • Imaging (X-Ray/MRI) Support
Best for Recovery
4.9

Enteropathy-type (intestinal) T-cell lymphoma Recovery Package

12,49918,000

All Inclusive Price

  • 10 Physiotherapy Sessions
  • Dietary Consultation
  • 24/7 Support Assistant

Complete Guide to Enteropathy-type (intestinal) T-cell lymphoma

Everything you need to know about this condition

What is Enteropathy-type (intestinal) T-cell lymphoma?

Enteropathy-type T-cell lymphoma is a rare and aggressive type of cancer that affects the immune system and the intestines. It is a type of non-Hodgkin lymphoma, which is a cancer of the lymphatic system. This type of cancer is also known as intestinal T-cell lymphoma or enteropathy-associated T-cell lymphoma. According to the World Health Organization (WHO), enteropathy-type T-cell lymphoma accounts for about 1-2% of all non-Hodgkin lymphomas.

Causes and Risk Factors

The exact cause of enteropathy-type T-cell lymphoma is not known, but it is often associated with celiac disease, a condition in which the immune system reacts to gluten. People with celiac disease have a higher risk of developing enteropathy-type T-cell lymphoma. Other risk factors include a family history of celiac disease or lymphoma, and a history of infections or inflammation in the intestines. Genetic factors may also play a role in the development of this cancer.

Signs and Symptoms

The symptoms of enteropathy-type T-cell lymphoma can vary depending on the location and extent of the cancer. Common symptoms include abdominal pain, diarrhea, weight loss, and fatigue. In some cases, people may experience vomiting, bloating, or abdominal tenderness. Early signs of the disease may be similar to those of celiac disease, such as diarrhea, abdominal pain, and weight loss. As the disease progresses, symptoms may become more severe and include bowel obstruction, perforation, or bleeding.

How is Enteropathy-type (intestinal) T-cell lymphoma Diagnosed?

Diagnosing enteropathy-type T-cell lymphoma can be challenging, as the symptoms are similar to those of other intestinal disorders. A diagnosis is typically made based on a combination of physical exams, imaging studies, lab work, and biopsy results. Imaging studies such as CT scans or MRI scans may show intestinal wall thickening or masses. Lab work may include blood tests to check for anemia, inflammation, or infection. A biopsy of the intestine may be performed to confirm the diagnosis and determine the extent of the disease.

Treatment Options

Treatment for enteropathy-type T-cell lymphoma depends on the stage and extent of the disease. According to the National Institute for Health and Care Excellence (NICE) guidelines, treatment options may include chemotherapy, radiation therapy, and surgery. Chemotherapy is often the primary treatment for this type of cancer, and may be used alone or in combination with radiation therapy. Surgery may be necessary to remove a portion of the intestine or to relieve a bowel obstruction. In some cases, a stem cell transplant may be recommended.

Home Care and Self-Management

While there is no cure for enteropathy-type T-cell lymphoma, there are steps you can take to manage your symptoms and improve your quality of life. Following a gluten-free diet may help manage symptoms in some cases. It is also important to stay hydrated, eat a balanced diet, and get regular exercise. You should also follow your doctor's instructions for taking medication, attending follow-up appointments, and reporting any changes in your symptoms.

Prevention Strategies

While there is no sure way to prevent enteropathy-type T-cell lymphoma, there are steps you can take to reduce your risk. If you have celiac disease, following a gluten-free diet may help reduce your risk of developing this type of cancer. You should also avoid smoking, maintain a healthy weight, and get regular check-ups with your doctor.

When to See a Doctor

If you are experiencing any of the following symptoms, you should seek medical attention immediately: severe abdominal pain, vomiting blood, black tarry stools, or difficulty breathing. You should also see a doctor if you have a family history of celiac disease or lymphoma, or if you have been diagnosed with celiac disease.

Living with Enteropathy-type (intestinal) T-cell lymphoma

Living with enteropathy-type T-cell lymphoma can be challenging, but there are many resources available to help you cope with the physical and emotional aspects of the disease. You may want to consider joining a support group or talking to a counselor to help you deal with the stress and anxiety of living with cancer. According to the Mayo Clinic, the 5-year survival rate for people with enteropathy-type T-cell lymphoma is around 20-30%. However, with proper treatment and care, many people are able to manage their symptoms and live for several years after diagnosis.

Dr. Dinesh Kumar

Written by Dr. Dinesh Kumar

MD, Specialist Physician • 15+ Years Experience

Last reviewed: May 2026

Crucial Medical Notice

This protocol is for informational purposes. If you are experiencing acute symptoms of Enteropathy-type (intestinal) T-cell lymphoma, please contact local emergency services or a qualified specialist immediately.

Need a Expert Second Opinion?

Consult with top-rated specialists who specialize in Enteropathy-type (intestinal) T-cell lymphoma within 15 minutes.

doctor
doctor
doctor

50+ Doctors Online

Clinical Governance

Reviewed by the Health Mudraa Clinical Council. Protocols are updated quarterly to align with NICE (UK) & WHO Global standards.

NICE
WHO
FDA

Expert-Led Treatments